Zocor Offer Draws Predatory Pricing Accusations
With a generic version of cholesterol drug Zocor hitting shelves today, an offer by Merck & Co. to provide the drug for below the generic price has some accusing the pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article